Friday, September 20, 2013

FDA to recall Gsunate Plus Suppository

Tobinco Pharmaceuticals Limited has outlined measures to assist the Food and Drugs Authority (FDA) to recall Gsunate Plus Suppository, an anti-malaria combination of Artesunate 25mg and Amodiaquine 75mg, from the market.

Tobinco, importers of the drug, has directed all hospitals, clinics, pharmacies, licensed chemical sellers and other health facilities having stocks of Gsunate Plus Suppository to immediately handover stocks to its Regional offices or the nearest FDA office countrywide for safe disposal.